Fidelity Investments’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.1K	Sell	8,495 -5,934	-41%	-$25.7K	﹤0.01%	4412
2025 Q4	$51.4K	Buy	14,429 +3,824	+36%	+$23.4K	﹤0.01%	4099
2025 Q3	$94.4K	Buy	10,605 +195	+2%	+$1.98K	﹤0.01%	3690
2025 Q2	$96K	Buy	10,410 +114	+1%	+$973	﹤0.01%	3622
2025 Q1	$88.3K	Buy	10,296 +1,368	+15%	+$12.9K	﹤0.01%	3612
2024 Q4	$95.9K	Buy	8,928 +526	+6%	+$4.05K	﹤0.01%	3564
2024 Q3	$47.7K	Sell	8,402 -4,884	-37%	-$28.2K	﹤0.01%	3802
2024 Q2	$56.1K	Buy	13,286 +11,541	+661%	+$46.7K	﹤0.01%	3557
2024 Q1	$8.88K	Sell	1,745 -7,502	-81%	-$42.2K	﹤0.01%	4324
2023 Q4	$86.1K	Buy	9,247 +8,396	+987%	+$57.8K	﹤0.01%	3275
2023 Q3	$5.57K	Sell	851 -1,111	-57%	-$8.84K	﹤0.01%	4300
2023 Q2	$16K	Buy	1,962 +562	+40%	+$4.82K	﹤0.01%	3964
2023 Q1	$12K	Buy	1,400 +338	+32%	+$3.37K	﹤0.01%	4057
2022 Q4	$9.84K	Sell	1,062 -637	-37%	-$6.8K	﹤0.01%	4020
2022 Q3	$17K	Sell	1,699 -44,346	-96%	-$468K	﹤0.01%	3904
2022 Q2	$461K	Buy	46,045 +298	+0.7%	+$2.82K	﹤0.01%	2873
2022 Q1	$563K	Buy	45,747 +45,710	+123,541%	+$562K	﹤0.01%	2948
2021 Q4	$1K	Sell	37 -2,500	-99%	-$47.5K	﹤0.01%	4093
2021 Q3	$46K	Buy	2,537 +2,492	+5,538%	+$49.6K	﹤0.01%	3231
2021 Q2	$1K	Buy	+45	New	+$666	﹤0.01%	3994